We conduct research in the following three core areas:
Interdisciplinary research at the intersection of law and medicine: Our objective is to improve access of patients and society to medicine in Europe, the US and around the world. Our focus lies on medicines, medical devices and digital health. We combine legal and empirical analysis and, based on the results, develop policies.
Interdisciplinary research at the intersection of law and technology: Our objective is to analyze the potential and challenges of emerging technologies (such as artificial intelligence-based applications), how innovative technologies are applied in the real world setting and how development and access could be fostered while mitigating risks. We combine legal and empirical analysis and, based on the results, develop policies.
Public law: We conduct traditional legal analysis in constitutional law and administrative law, often related but not limited to questions in medicine or innovative technologies.
Our studies are published in leading journals in law, medicine and science (e.g. Cell, Lancet, Lancet Oncology, Lancet Digital Health, JAMA, JAMA Oncology, JAMA Internal Medicine, BMJ, Nature Medicine, Nature Machine Intelligence, Cambridge University Press) and have been covered by the media (e.g., The New York Times, The LA Times, Boston Globe/Stat News, Forbes, Scientific American, SRF, Neue Zürcher Zeitung, Tagesanzeiger).
We collaborate closely with academics from other universities, for example, Harvard Medical School, London School of Economics and Political Science, or Technical University Munich.
Our research is funded by the Swiss National Science Foundation (SNSF), the Swiss Cancer Research Foundation (Krebsforschung Schweiz) and Kaiser Permanente Institute for Health Policy.
We advise governments (e.g., Federal Office of Public Health, Federal Department of Foreign Affairs) and international organizations (e.g., UN) in our areas of expertise.